MENU
+Compare
INKT
Stock ticker: NASDAQ
AS OF
Dec 18, 02:09 PM (EDT)
Price
$0.55
Change
+$0.01 (+1.85%)
Capitalization
21.31M

INKT MiNK Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for INKT with price predictions
Dec 17, 2024

INKT's Stochastic Oscillator stays in oversold zone for 5 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INKT advanced for three days, in of 133 cases, the price rose further within the following month. The odds of a continued upward trend are .

INKT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 10, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on INKT as a result. In of 62 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for INKT turned negative on December 04, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 31 similar instances when the indicator turned negative. In of the 31 cases the stock turned lower in the days that followed. This puts the odds of success at .

INKT moved below its 50-day moving average on December 04, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for INKT crossed bearishly below the 50-day moving average on November 26, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INKT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for INKT entered a downward trend on December 17, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). INKT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (260.687).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. INKT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INKT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

INKT is expected to report earnings to rise 67.80% to -8 cents per share on March 19

MiNK Therapeutics INKT Stock Earnings Reports
Q4'24
Est.
$-0.08
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.03
Q1'24
Beat
by $0.04
Q4'23
Missed
by $0.01
The last earnings report on November 14 showed earnings per share of -5 cents, beating the estimate of -8 cents. With 10.32K shares outstanding, the current market capitalization sits at 21.31M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
149 Fifth Avenue
Phone
+1 212 994-8250
Employees
31
Web
https://www.minktherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DALN5.120.04
+0.79%
DallasNews Corp
ARR19.03-0.14
-0.73%
ARMOUR Residential REIT
LAZ52.74-0.67
-1.25%
Lazard
HUBB439.53-16.29
-3.57%
Hubbell
AEVA4.05-0.20
-4.71%
Aeva Technologies

INKT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been loosely correlated with CADL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INKT jumps, then CADL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
-7.12%
CADL - INKT
41%
Loosely correlated
+7.23%
VINC - INKT
39%
Loosely correlated
-0.31%
NKTR - INKT
34%
Loosely correlated
+2.00%
ABCZF - INKT
33%
Loosely correlated
N/A
TERN - INKT
30%
Poorly correlated
-2.58%
More